Smartphone app aims to prevent strokes by catching silent atrial fibrillation

NCT ID NCT07684053

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This large study tests whether a smartphone app can help prevent strokes by detecting atrial fibrillation (an irregular heartbeat) early. Adults aged 65 and older in Austria are randomly assigned to use the 'Pulskontrolle' app for pulse checks or to receive usual care. If the app finds a possible problem, a 7-day ECG patch confirms the diagnosis, and participants get digital support. The main goal is to see if this approach reduces hospitalizations for stroke over 48 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Smartphone-based atrial fibrillation screening app (Pulskontrolle) with confirmatory ECG patch
What this could lead to
If effective, this approach could prevent thousands of strokes by catching hidden atrial fibrillation early using just a smartphone.
What could go wrong
The screening may miss some cases or cause false alarms, and it's unclear if digital management will reduce strokes more than usual care in a real-world setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (PREVENTION OF STROKE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Internal Medicine III, Medical University Innsbruck

    RECRUITING

    Innsbruck, Tyrol, 6020, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.